Skip to content

Coercive Control and Intimate Partner Violence

Coercive Control and Intimate Partner Violence: Examining the Relationships Between Exposure to Violence and Victims' Physical and Mental Health Outcomes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07578194
Acronym
CCVCS
Enrollment
250
Registered
2026-05-11
Start date
2026-05-30
Completion date
2028-05-30
Last updated
2026-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coercive Control

Keywords

partner violence

Brief summary

Coercive control (CC) is increasingly recognized as a central component of intimate partner violence (IPV) and a major determinant of victims' health outcomes. While widely integrated into policy and legal frameworks in several countries, CC remains insufficiently explored in the French research context, particularly regarding its clinical and psychopathological dimensions. This gap may limit the identification of victims and the provision of appropriate care. The present study aims to investigate the association between exposure to coercive control and physical and mental health outcomes among victims of intimate partner violence. By improving the understanding of CC-related health impacts, this research seeks to support better identification of high-risk situations and inform clinical and public health interventions.

Interventions

OTHERquestionnaire

Participants will complete online questionnaires via the Qualtrics platform at baseline and at 6 months post-enrollment

Sponsors

Centre Hospitalier Intercommunal Robert Ballanger
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women aged 18 years and older, who have experienced an intimate partner relationship involving violence for at least three months (currently in the relationship or separated). * Women identified as victims of intimate partner violence. * Sufficient proficiency in French to complete self-administered questionnaires and participate in interviews. * No objection to participation in the study (non-opposition). * Affiliation with a French social security scheme or eligibility for universal health coverage (Couverture Maladie Universelle, CMU).

Exclusion criteria

* Individuals under legal protection in accordance with the French Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2), with the exception of pregnant or breastfeeding women. * Cognitive impairment or severe intellectual disability preventing comprehension of the questionnaires. * Severe and unstable psychiatric disorders (e.g., schizophrenia, delusional disorders, acute bipolar disorder).

Design outcomes

Primary

MeasureTime frameDescription
Coercive Control Screening ScaleMeasure of CCSS between inlusion and month 6Measure of Coercive Control Screening Scale (CCSS). Minimal scale = 0, maximal scale = 44. Higher score means worse outcome

Secondary

MeasureTime frameDescription
Measure of Hospital Anxiety and Depression scale (HAD scale)Measure of HHAD scale between inclusion and month 6correlation between HAD scale and CCSS scale. Minimal scale = 0, maximal scale = 42. Higher score means worse outcome
Severity of post-traumatic stress disorder symptomsat inclusion and month 6Severity of post-traumatic stress disorder (PTSD) symptoms assessed by the PTSD Checklist for DSM-5 (PCL-5), based on total score and DSM-5 clinical thresholds. Minimal scale = 0, maximal scale = 80. Higher score means worse outcome
International Trauma Questionnaire (ITQ).Inclusion and month 6International Trauma Questionnaire (ITQ), according to ICD-11 criteria. Minimal scale = 0, maximal scale = 72. Higher score means worse outcome
Severity of emotional dysregulationinclusion and month 6Severity of emotional dysregulation assessed using the Difficulties in Emotion Regulation Scale - French version (DERS-F). Minimal scale = 36, maximal scale = 180. Higher score means worse outcome
Short Form Health Survey (SF-12)inclusion and month 6Health-related quality of life assessed using the 12-Item Short Form Health Survey (SF-12), including physical and mental component summary scores. optimal scale more than 40. scale \< 40 means worse outcome
Brief Pain Inventoryat inclusion and month 6Pain intensity and functional impact assessed using the Brief Pain Inventory (BPI). mninimal scale = 0, maximal scale = 10. Higher score means worse outcome
Coercive Control Scale (CCSS)inclusion and month 6Analysis of score distribution on the Coercive Control Scale (CCSS) to determine a clinically relevant threshold for coercive control. Minimal scale = 0, maximal scale = 44. Higher score means worse outcome
Woman Abuse Screening Tool (WAST)inclusion and month 6Intimate partner violence assessed using the Woman Abuse Screening Tool (WAST). minimal scale = 0, maximal scale = 16. Higher score means worse outcome

Countries

France

Contacts

CONTACTFatima F LE GRIGUER, Principal Investigator
fatima.le-griguer@ght-gpne.fr00 33 1 49 36 72 38
PRINCIPAL_INVESTIGATORfatima F Le Griguer, psychologist

CHI Robert Balanger of GHT GPNE

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 27, 2026